Safety and Efficacy of Dual PPAR- Alpha Agonist, Saroglitazar, in Management of NAFLD with Diabetes and/or Dyslipidemia in Liver Transplant Recipients.

Subjects

Subjects :

*LIVER transplantation
*NON-alcoholic fatty liver disease
*DYSLIPIDEMIA
*DIABETES
*SAFETY

Details

Language :

English

ISSN :

09736883

Volume :

13

Database :

Academic Search Index

Journal :

Journal of Clinical & Experimental Hepatology

Publication Type :

Academic Journal

Accession number :

166106586

Full Text :

https://doi.org/10.1016/j.jceh.2023.07.188